Showing results (311-320 of 361) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2025
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort studyAdrià Tort-Merino, Agnès Pérez-Millan, Neus Falgàs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2022
Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite SymposiumClaire Sexton, Michele Solis, Judith Aharon-Peretz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2021
Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserveIgnacio Illán-Gala, Kaitlin B Casaletto, Sergi Borrego-Écija, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid BiomarkersLinda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJudit Selma-Gonzalez, Sara Rubio-Guerra, Jesús Garcia Castro, et al.
Brain Communications|April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndromeM Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Molecular Syndromology|August 23, 2021
Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research SocietyMara Dierssen, Yann Herault, Pablo Helguera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer's DiseaseAina Bellver-Sanchis, David Valle-Garcia, Carla Barbaraci, et al.
Molecular Psychiatry|October 9, 2025
Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI studyElena Rodriguez-Vieitez, Melissa T Rydell, Abbe Ullgren, et al.
Pageof 37